Troponin I: in sickness and in health-and normal development

Titin-related familial dilated cardiomyopathy: factors associated with disease onset.

European heart journal·2025

Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.

Circulation. Heart failure·2025

Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy.

JAMA cardiology·2025

Arg92Leu-cTnT Alters the cTnC-cTnI Interface Disrupting PKA-Mediated Relaxation.

Circulation research·2024

Relationship-based practice and digital technology in child and family social work: Learning from practice during the COVID-19 pandemic.

Developmental child welfare·2024

Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.

JAMA cardiology·2023

RNA-Binding Protein MBNL2 Drives Cardiac Hypertrophy and Dysfunction by Facilitating TPM3 Splicing.

Circulation research·2026

Gut Dysbiosis Promotes Myocardial Hypertrophy via GBP2b/GBP1 in Chronic Colitis.

Circulation research·2026

Blood Metabolomic Signatures of 1-Hour Glucose Predict Cardiometabolic Risk.

Circulation research·2026

Hepatic ChREBP Drives Cardiac Remodeling via ApoM Nontranscriptional Repression.

Circulation research·2026

Mitophagy Facilitates Cytosolic Proteostasis to Preserve Cardiac Function.

Circulation research·2026

Regulated HSPG Signaling Directs Epicardial Behavior to Support Cardiac Formation.

Circulation research·2026

[Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026

Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.

Frontiers in pharmacology·2026

Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis.

International journal of cardiology. Cardiovascular risk and prevention·2026

Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma.

Frontiers in pediatrics·2026

Elevated IGF-1 levels are associated with accelerated bone age advancement during growth hormone therapy in children: a multicenter cohort study.

Frontiers in endocrinology·2026

Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome.

Haematologica·2026

Related Experiment Videos

Troponin I: in sickness and in health-and normal development

Related Concept Videos

Titin-related familial dilated cardiomyopathy: factors associated with disease onset.

Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.

Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy.

Arg92Leu-cTnT Alters the cTnC-cTnI Interface Disrupting PKA-Mediated Relaxation.

Relationship-based practice and digital technology in child and family social work: Learning from practice during the COVID-19 pandemic.

Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.

RNA-Binding Protein MBNL2 Drives Cardiac Hypertrophy and Dysfunction by Facilitating TPM3 Splicing.

Gut Dysbiosis Promotes Myocardial Hypertrophy via GBP2b/GBP1 in Chronic Colitis.

Blood Metabolomic Signatures of 1-Hour Glucose Predict Cardiometabolic Risk.

Hepatic ChREBP Drives Cardiac Remodeling via ApoM Nontranscriptional Repression.

Mitophagy Facilitates Cytosolic Proteostasis to Preserve Cardiac Function.

Regulated HSPG Signaling Directs Epicardial Behavior to Support Cardiac Formation.

[Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury].

Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.

Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis.

Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma.

Elevated IGF-1 levels are associated with accelerated bone age advancement during growth hormone therapy in children: a multicenter cohort study.

Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome.

Related Experiment Videos

Troponin I: in sickness and in health-and normal development

Related Concept Videos

Related Articles